Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF - Žáčková, Daniela; Semerád, Lukáš; Faber, Edgar; Klamová, Hana; Stejskal, Lukáš; Bělohlávková, Petra; Karas, Michal; Cmunt, Eduard; Černá, Olga; Procházková, Jiřina; Čičátková, Petra; Kvetková, Anežka; et al. (Leukemia, 2024)
Keywords: Tyrosine Kinase Inhibitors; inhibitory tyrosinkinasy; Česká republika; Protein Kinase Inhibitors; Czech Republic; chronická nemoc; myeloidní leukemie; Leukemia, Myeloid; lidé; inhibitory proteinkinas; Humans; Chronic Disease; chronická myeloidní leukemie; Leukemia, Myelogenous, Chronic, BCR-ABL Positive